Next issueIssue 20 · Tue 27 Oct 

Trials

2024-519844-34-03

Trial ID
T-ctis-2024-519844-34-03
Registry
EU Clinical Trials Information System
CTIS number
2024-519844-34-03
Sponsor, as registered
Universita' Degli Studi G. D'Annunzio Di Chieti
Phase
Therapeutic exploratory (Phase II)
Indication
Treatment Resistant Depression (TRD)
Status
Authorised
Start date
19/01/2026
Primary completion
CTIS does not publish one.
Member states concerned
Italy
Sites
3

Member states whose regulator has a decision on this trial.

euclinicaltrials.euctis registryverified 2026-10-19

Notes on the record

New to data/trials.csv (no row for this CT number on main as of 2026-10-19); found by CTIS public search productName=psilocybin. Fields read from the CTIS public API retrieve record on 2026-10-19 17:33 CEST (publishDate 2026-02-03T02:31); site_count is the sum of trialSites across authorizedPartsII; codes not decoded; no primary completion date published.

Cited in

No published issue cites this registry number.